Regeneron Pharma (REGN) PT Lowered to $700 at RBC Capital
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $836.92 -0.78%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $700.00 (from $702.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)
- Toro (TTC) PT Lowered to $115 at DA Davidson
- BRP Inc. (DOO:CN) (DOOO) PT Raised to Cdn$110 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
